https://sputniknews.in/20260414/russian-scientists-make-incredible-breakthrough-against-cancer-10752725.html
Russian Scientists Make Incredible Breakthrough Against Cancer
Russian Scientists Make Incredible Breakthrough Against Cancer
Sputnik India
Regulators have approved the clinical use of Oncorna – a new personalized neoantigen mRNA vaccine developed to treat colorectal cancer. 14.04.2026, Sputnik India
2026-04-14T11:37+0530
2026-04-14T11:37+0530
2026-04-14T11:37+0530
russia
health
science & tech
russia
cancer
https://cdn1.img.sputniknews.in/img/07e9/01/1b/8708493_0:159:2802:1735_1920x0_80_0_0_71c5aaf3a55d3b2210cff6f3b5ffc2e8.jpg
Oncorna is the second treatment for this type of cancer to be approved, following Oncopept's approval in late 2025. The latter was administered to its first patient in March.Both vaccines were developed by the Federal Medical and Biological Agency, a body subordinated to the president.The vaccines are personalized – custom-made and administered to fit patients' unique tumor and immune system profiles, while incorporating advanced technologies including AI.So far, besides colorectal cancer, treatments have been developed for pancreatic, kidney, lung, brain, and other cancers.
https://sputniknews.in/20260413/russian-gymnasts-secure-gold-and-medals-in-tashkent-world-cup-stage-10749329.html
russia
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2026
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_IN
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
health, science & tech, russia, cancer
health, science & tech, russia, cancer
Russian Scientists Make Incredible Breakthrough Against Cancer
Regulators have approved the clinical use of Oncorna – a new personalized neoantigen mRNA vaccine developed to treat colorectal cancer.
Oncorna is the second treatment for this type of cancer to be approved, following Oncopept's approval in late 2025. The latter was administered to its first patient in March.
Both vaccines were developed by the Federal Medical and Biological Agency, a body subordinated to the president.
The twin breakthroughs are part of Russia's broader exploration of mRNA-based therapies designed to help train a compromised immune system to recognize and destroy tumor cells.
The
vaccines are personalized – custom-made and administered to fit patients' unique tumor and immune system profiles, while incorporating advanced technologies including AI.
So far, besides colorectal cancer, treatments have been developed for pancreatic, kidney, lung, brain, and other cancers.
